<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02046707</url>
  </required_header>
  <id_info>
    <org_study_id>CASILLAS Fondation Av 2008</org_study_id>
    <nct_id>NCT02046707</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure</brief_title>
  <official_title>Evaluation of the Effects of Eccentric Muscle Training Versus Conventional Concentric Training in Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      This is a single-centre open randomized parallel-group study. Patients will be selected at&#xD;
      random to be included in group 1: eccentric rehabilitation or group 2: conventional&#xD;
      rehabilitation.&#xD;
&#xD;
      In addition, a group of healthy volunteers aged between 20 and 85 years will also be&#xD;
      recruited. This group will make it possible to evaluate, during the two exercise sessions,&#xD;
      mechanisms of adaptation linked to eccentric exercise vs concentric exercise.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 29, 2014</start_date>
  <primary_completion_date type="Actual">March 23, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of performance in the 6-minute walk test between the initial assessment and the final assessment of a reconditioning programme</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of functional and physiological capacities and tolerance criteria</measure>
    <time_frame>12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Reconditioning to Effort</condition>
  <arm_group>
    <arm_group_label>Patients with chronic heart failure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>initial evaluation</intervention_name>
    <arm_group_label>Patients with chronic heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Period of cardiac rehabilitation</intervention_name>
    <arm_group_label>Patients with chronic heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>final evaluation</intervention_name>
    <arm_group_label>Patients with chronic heart failure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Concentric and eccentric exercise sessions</intervention_name>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients :&#xD;
&#xD;
          -  Patients who have provided written informed consent&#xD;
&#xD;
          -  Patients with national health insurance cover&#xD;
&#xD;
          -  Men or women aged between 45 and 85 years with stabilized chronic heart failure&#xD;
             (ischemic or dilated cardiopathy) for at least one month, New York Heart Association&#xD;
             stage&gt; 2.&#xD;
&#xD;
          -  Echocardiographic left ventricular ejection fraction (Simpson method) &lt; 45% OR&#xD;
             N-terminal-ProBNP &gt; 3 x upper limit of normal* (*= 125pg/ml for the CHU laboratory).&#xD;
&#xD;
          -  First period of rehabilitation for chronic heart failure.&#xD;
&#xD;
        Healthy volunteers:&#xD;
&#xD;
          -  Subjects who have provided written informed consent&#xD;
&#xD;
          -  Subjects with national health insurance cover&#xD;
&#xD;
          -  Men or women aged between 18 and 85 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  persons without national health insurance cover&#xD;
&#xD;
          -  Severe obstructive cardiopathy,&#xD;
&#xD;
          -  severe aortic valve stenosis,&#xD;
&#xD;
          -  severe progressive heart rhythm or conduction disorders not corrected with a&#xD;
             pacemaker, discovered at the initial effort test&#xD;
&#xD;
          -  intra-cavitary thrombus,&#xD;
&#xD;
          -  severe pulmonary artery hypertension (systolic pulmonary arterial hypertension&#xD;
             &gt;70mmHg),&#xD;
&#xD;
          -  recent history of venous trombo-embolism (last 3 months),&#xD;
&#xD;
          -  impaired executive function making it impossible to understand and follow&#xD;
             reconditioning programme (Mini Mental Test &lt; 24),&#xD;
&#xD;
          -  heart transplant,&#xD;
&#xD;
          -  associated medical disorders that could predominately impair functional capacity&#xD;
             compared with the chronic heart failure (examples: respiratory insufficiency,&#xD;
             non-stabilized metabolic disorders such as progressive kidney failure, severe asthenia&#xD;
             related to a severe non-stabilized disorder such as neoplasia, systemic disease…).&#xD;
&#xD;
        associated chronic motor deficit of a neurological origin (example: sequelae of a&#xD;
        cerebrovascular accident), an osteo-articular origin (example: impairment due to Rheumatoid&#xD;
        arthritis), of a peripheral vascular disease (example: peripheral artery disease, venous&#xD;
        disease, lymphedema) will not be included in the exclusion criteria provided thay are&#xD;
        compatible with the level of physical ability defined in the inclusion criteria. The&#xD;
        presence of an implantable pacemaker and/or defibrillator will not be an exclusion&#xD;
        criterion&#xD;
&#xD;
        Healthy volunteers:&#xD;
&#xD;
          -  persons without national health insurance cover&#xD;
&#xD;
          -  Any organic disorder whatever its nature (cardiac, respiratory, neurological,&#xD;
             orthopedic, …) that could affect adaptation to effort or is a contra-indication for&#xD;
             physical activity.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>January 20, 2014</study_first_submitted>
  <study_first_submitted_qc>January 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2014</study_first_posted>
  <last_update_submitted>May 3, 2019</last_update_submitted>
  <last_update_submitted_qc>May 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

